Skip to main content

John McAuliffe

NIH Rank #27664
  • Early Career
  • Mentor

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 9442423Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

NIH Funding · FY2024

Linked Award Amount
$574K
Full award amounts, FY2024
Award Records
2
Records listing this PI
Award-Linked Rank
#27,664
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for John McAuliffe. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2024 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2024 award records by amount

NIH award records listing John McAuliffe as a PI. Multi-PI records show the full award amount for context.

  • 1R42CA287679-01R42
    Clinical testing of Listeria-TT and Gemcitabine in a Phase I clinical trial with PDAC patients
    $295K
    award amount
  • 5T32CA200561-11T32
    Training of Surgeon Scientists in Basic and Translational Cancer Research
    $279K
    award amount

Award organizations

Organizations that administered FY2024 awards listing John McAuliffe as a PI.

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    Loki Therapeutics, Inc
  2. 2024
    $500K Cumulative Funding
  3. 2026
    Multi-Institutional Research
    Awards at 2 institutions